drugset / Trial / NCT00004403

Randomized Study of Albendazole in Patients With Epilepsy Due to Neurocysticercosis

NCT00004403

Completed 120 enrolled Johns Hopkins University
RandomizedDouble-blindTreatment

Summary

OBJECTIVES: I. Determine the effect of antiparasitic treatment with albendazole on the severity and duration of epilepsy due to neurocysticercosis. II. Determine the effect of a short course of albendazole on Taenia solium cysts present in the brain. III. Determine the natural regression of cerebral T. solium cysts in patients given placebo and their response to treatment at the end of the study.

Timeline

Start
2000-05
Primary completion
Completion
2002-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Albendazole Small molecule Oral
Subject Dexamethasone Small molecule Oral
Background Phenytoin Unknown

Indications